Researchers found the walls of the brain’s small arteries are also affected in Alzheimer’s, reducing blood flow. Learn about this new treatment target.
Amyloid Scans diagnose and treat Alzheimer’s, at a hefty price. 11 years after FDA approval, Medicare can finally help.
Research shows that a blood test now on the market accurately identifies brain amyloid status with a single blood sample. In other words, this blood test can diagnose Alzheimer’s.
Early evidence indicates that ketogenic therapy is a safe and effective treatment for Alzheimer’s Disease and other forms of dementia. Dr. Stephen Cunnane discusses how ketogenic therapies can help.
FDA-approved Sargramostim, a normal human protein, improved memory and cognition in Alzheimer’s patients in a Phase II clinical trial. The drug is safe and well-tolerated, and has been used for other disorders for 30 years.
A neuroradiologist at the Mayo Clinic in Jacksonville, FL warns that increased use of monoclonal antibody treatment for Alzheimer’s has also led to the discovery of amyloid-related imaging abnormalities — ARIA. Find out more.
The first drugs for Alzheimer’s disease emerged in the 1990s, but since then there has been a wave of clinical trial failures, major companies pulling resources from neuroscience R&D, and progress.
A fascinating study in Europe finds that individuals who felt they had memory problems did in fact have measurable cognitive deficits. Scientists analyzed the spinal fluid to measure the levels of biomarkers associated with Alzheimer’s.
Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.
Swiss researchers find that people with certain personality traits are protected against Alzheimer’s disease, including those who are less agreeable, had natural curiosity, and were nonconformists. Find out why.
Dietary iron is an essential element in the brain. That’s why it is critical to understand how it affects Alzheimer’s. Researchers used advanced X-ray techniques to take a giant step forward in understanding iron chemistry in amyloid plaque, the main culprit behind Alzheimer’s. Learn more about their exciting new insights.
A deep promise to be there for an Alzheimer’s parent, this heartwarming song was written as a tribute to families facing dementia.
EMERGENCIES due to falling happen 54% more often in dementia. As a rule, 1-in-3 adults over 65 fall each year. Most falls happen at home. Make a few simple changes and prevent falls.
People worry about becoming forgetful. Is it the first sign of Alzheimer’s or just the passing years? After all, forgetfulness is a normal part of aging. Check out these quick ways to tell the difference.
Researchers found in a study that people who developed dementia were more likely to have their credit rating drop at least two and a half years before the diagnosis. Some had problems managing their money up to six years before. Find out more.
Scientists say restoring a brain protein, not removing amyloid plaques, should be the target of Alzheimer’s dementia therapies. The researchers said treatment might lie in normalizing the levels of a specific brain protein.
Dietary iron is an essential element in the brain. That’s why it is critical to understand how it affects Alzheimer’s. Researchers used advanced X-ray techniques to take a giant step forward in understanding iron chemistry in amyloid plaque, the main culprit behind Alzheimer’s. Learn more about their exciting new insights.
No spam, only news and updates.
